"Int J Mol Cell Med"[jour] - Search Results

Year	Number of Results
2012	29
2013	32
2014	37
2015	31
2016	31
2017	29
2018	27
2019	37
2020	28
2021	0

1

Down Syndrome: Current Status, Challenges and Future Perspectives.

Kazemi M, Salehi M, Kheirollahi M. Kazemi M, et al. Int J Mol Cell Med. 2016 Summer;5(3):125-133. Epub 2016 Aug 10. Int J Mol Cell Med. 2016. PMID: 27942498 Free PMC article. Review.

2

Novel Insight to Neuroprotective Potential of Curcumin: A Mechanistic Review of Possible Involvement of Mitochondrial Biogenesis and PI3/Akt/ GSK3 or PI3/Akt/CREB/BDNF Signaling Pathways.

Kandezi N, Mohammadi M, Ghaffari M, Gholami M, Motaghinejad M, Safari S. Kandezi N, et al. Int J Mol Cell Med. 2020 Winter;9(1):1-32. doi: 10.22088/IJMCM.BUMS.9.1.1. Int J Mol Cell Med. 2020. PMID: 32832482 Free PMC article. Review.

3

Gastric Cancer MicroRNAs Meta-signature.

Zare A, Ganji M, Omrani MD, Alipoor B, Ghaedi H. Zare A, et al. Int J Mol Cell Med. 2019 Spring;8(2):94-102. doi: 10.22088/IJMCM.BUMS.8.2.94. Epub 2019 Aug 24. Int J Mol Cell Med. 2019. PMID: 32215261 Free PMC article. Review.

4

Metabolomics and Cell Therapy in Diabetes Mellitus.

Larijani B, Goodarzi P, Payab M, Alavi-Moghadam S, Rahim F, Bana N, Abedi M, Arabi M, Adibi H, Gilany K, Arjmand B. Larijani B, et al. Int J Mol Cell Med. 2019 Winter;8(Suppl1):41-48. doi: 10.22088/IJMCM.BUMS.8.2.41. Epub 2019 May 30. Int J Mol Cell Med. 2019. PMID: 32351908 Free PMC article. Review.

5

Precision Medicine in Non Communicable Diseases.

Hasanzad M, Sarhangi N, Aghaei Meybodi HR, Nikfar S, Khatami F, Larijani B. Hasanzad M, et al. Int J Mol Cell Med. 2019 Winter;8(Suppl1):1-18. doi: 10.22088/IJMCM.BUMS.8.2.1. Epub 2019 Jul 25. Int J Mol Cell Med. 2019. PMID: 32351905 Free PMC article. Review.

6

Metabolomics Analysis of Mesenchymal Stem Cells.

Goodarzi P, Alavi-Moghadam S, Payab M, Larijani B, Rahim F, Gilany K, Bana N, Tayanloo-Beik A, Foroughi Heravani N, Hadavandkhani M, Arjmand B. Goodarzi P, et al. Int J Mol Cell Med. 2019 Winter;8(Suppl1):30-40. doi: 10.22088/IJMCM.BUMS.8.2.30. Epub 2019 Jun 20. Int J Mol Cell Med. 2019. PMID: 32351907 Free PMC article. Review.

7

The Role of ERRFI1+808T/G Polymorphism in Diabetic Nephropathy.

Asgarbeik S, Mohammad Amoli M, Enayati S, Bandarian F, Nasli-Esfahani E, Forouzanfar K, Razi F, Angaji SA. Asgarbeik S, et al. Int J Mol Cell Med. 2019 Winter;8(Suppl1):49-55. doi: 10.22088/IJMCM.BUMS.8.2.49. Epub 2019 Jun 15. Int J Mol Cell Med. 2019. PMID: 32351909 Free PMC article.

8

Association of MicroRNA-155rs767649 Polymorphism with Susceptibility to Preeclampsia.

Ayoub SE, Shaker OG, Abdelwahed MY, Ahmed NA, Abdelhameed HG, Bosilah AH, Mohammed SR. Ayoub SE, et al. Int J Mol Cell Med. 2019 Fall;8(4):247-257. doi: 10.22088/IJMCM.BUMS.8.4.247. Int J Mol Cell Med. 2019. PMID: 32587835 Free PMC article.

9

Rab11 in disease progression.

Bhuin T, Roy JK. Bhuin T, et al. Int J Mol Cell Med. 2015 Winter;4(1):1-8. Int J Mol Cell Med. 2015. PMID: 25815277 Free PMC article. Review.

10

Inhibitor of Interleukin-1 Receptor-associated Kinases 1/4, Can Increase the Sensitivity of Breast Cancer Cells to Methotrexate.

Rahemi S, Nematollahi-Mahani SN, Rajaie A, Fallah H. Rahemi S, et al. Int J Mol Cell Med. 2019 Summer;8(3):200-209. doi: 10.22088/IJMCM.BUMS.8.3.200. Int J Mol Cell Med. 2019. PMID: 32489949 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results